Prospective validation and refinement of the APPROACH cardiovascular surgical intensive care unit readmission score.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
12 2019
Historique:
received: 13 02 2019
revised: 03 07 2019
accepted: 07 08 2019
pubmed: 20 8 2019
medline: 29 7 2020
entrez: 18 8 2019
Statut: ppublish

Résumé

The APPROACH cardiovascular surgical intensive care unit (CVICU) readmission score has excellent discrimination and calibration for CVICU readmission after discharge to a surgical ward; however, it has not been prospectively validated. In a prospective consecutive cohort of 805 patients ≥18 years admitted to the CVICU after coronary artery bypass and/or valvular surgery, the APPROACH CVICU readmission score was calculated at the time of discharge to a surgical ward. The study compared observed versus predicted CVICU readmission and the model discrimination was evaluated using AUC c-index. The incremental prognostic utility of 6 pre-specified prospectively collected respiratory (re-intubation, tracheostomy, oxygen at discharge) and hemodynamic variables (heart rate, systolic blood pressure, inotropes at discharge) were tested using net reclassification index (NRI) and integrated discrimination improvement (IDI). A total of 37 (4.6%) patients were readmitted to the CVICU. The median CVICU length of stay (9.0 vs 2.0 days, p < .001) and all-cause in-hospital mortality (8.1% vs 0.4%, p < .001) was higher among readmitted patients. The model had good discrimination (c-index = 0.748). Systolic blood pressure at discharge yielded the largest improvement in model discrimination (c-index = 0.782; Hosmer-Lemshow p = .749). In a prospective validation cohort, the APPROACH CVICU readmission risk score had good discrimination and could be operationalized in future research and clinical practice.

Identifiants

pubmed: 31421527
pii: S0883-9441(19)30242-4
doi: 10.1016/j.jcrc.2019.08.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-121

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sanam Verma (S)

Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada.

Danielle A Southern (DA)

O'Brien Institute for Public Health, Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Ismail R Raslan (IR)

Division of Cardiology, University of Toronto, Toronto, Canada.

Colleen M Norris (CM)

Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada; School of Public Health, University of Alberta, Edmonton, Canada; Division of Cardiac Surgery, Department of Surgery, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada.

Michelle M Graham (MM)

Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada.

Sean M Bagshaw (SM)

Department of Critical Care, University of Alberta, Edmonton, Alberta, Canada.

Jayan Nagendran (J)

Division of Cardiac Surgery, Department of Surgery, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada.

Todd Maclure (T)

Department of Critical Care, University of Alberta, Edmonton, Alberta, Canada.

Louise Y Sun (LY)

Division of Cardiac Anesthesiology, University of Ottawa Heart Institute, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; Institute for Clinical Evaluative Sciences, Ontario, Canada.

Wu Dat Chin (WD)

Department of Critical Care, University of Alberta, Edmonton, Alberta, Canada.

Sean van Diepen (S)

Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada; Department of Critical Care, University of Alberta, Edmonton, Alberta, Canada; Canadian Vigour Center, University of Alberta, Edmonton, Alberta, Canada. Electronic address: sv9@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH